CoChat

Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies

Open access
Jette, Claudia A., Cohen, Alexander A., Gnanapragasam, Priyanthi N.P., Muecksch, Frauke, Lee, Yu E., Huey-Tubman, Kathryn E., Schmidt, Fabian, Hatziioannou, Theodora, Bieniasz, Paul D., Nussenzweig, Michel C., West, Anthony P., Keeffe, Jennifer R., Bjorkman, Pamela J., Barnes, Christopher O. · 2021 · Cell Reports

Published version of a preprint

Cited by 116

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Many anti-SARS-CoV-2 neutralizing antibodies target the ACE2-binding site on viral spike receptor-binding domains (RBDs). The most potent antibodies recognize exposed variable epitopes, often rendering them ineffective against other sarbecoviruses and SARS-CoV-2 variants. Class 4 anti-RBD antibodies against a less-exposed, but more-conserved, cryptic epitope could recognize newly-emergent zoonotic sarbecoviruses and variants, but usually show only weak neutralization potencies. We characterized two class 4 anti-RBD antibodies derived from COVID-19 donors that exhibited broad recognition and potent neutralization of zoonotic coronavirus and SARS-CoV-2 variants. C118-RBD and C022-RBD structures revealed CDRH3 mainchain H-bond interactions that extended an RBD β-sheet, thus reducing sensitivity to RBD sidechain changes, and epitopes that extended from the cryptic epitope to occlude ACE2 binding. A C118-spike trimer structure revealed rotated RBDs to allow cryptic epitope access and the potential for intra-spike crosslinking to increase avidity. These studies facilitate vaccine design and illustrate potential advantages of class 4 RBD-binding antibody therapeutics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2021.109760

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Research works printed but not linked: 68

  1. Adams, 2010, PHENIX: a comprehensive Python-based system for macromolecular structure solution, Acta Crystallogr. D Biol. Crystallogr., 66, 213, 10.1107/S0907444909052925 · DOI · Paper page
  2. Annavajhala, 2021, A Novel SARS-CoV-2 Variant of Concern, B.1.526, Identified in New York, medRxiv
  3. Bell, 2016, High resolution single particle refinement in EMAN2.1, Methods, 100, 25, 10.1016/j.ymeth.2016.02.018 · DOI · Paper page
  4. Bunkóczi, 2011, Improvement of molecular-replacement models with Sculptor, Acta Crystallogr. D Biol. Crystallogr., 67, 303, 10.1107/S0907444910051218 · DOI · Paper page
  5. Cao, 2020, Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients’ B cells, Cell, 182, 73, 10.1016/j.cell.2020.05.025 · DOI · Paper page
  6. Chan, 2020, Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2, Science, 369, 1261, 10.1126/science.abc0870 · DOI · Paper page
  7. Chen, 2010, MolProbity: all-atom structure validation for macromolecular crystallography, Acta Crystallogr. D Biol. Crystallogr., 66, 12, 10.1107/S0907444909042073 · DOI · Paper page
  8. Cohen, 2021, Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice, Science, 371, 735, 10.1126/science.abf6840 · DOI · Paper page
  9. Corti, 2010, Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine, J. Clin. Invest., 120, 1663, 10.1172/JCI41902 · DOI · Paper page
  10. Crawford, 2020, Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays, Viruses, 12, 513, 10.3390/v12050513 · DOI · Paper page
  11. Edgar, 2004, MUSCLE: multiple sequence alignment with high accuracy and high throughput, Nucleic Acids Res., 32, 1792, 10.1093/nar/gkh340 · DOI · Paper page
  12. Emsley, 2010, Features and development of Coot, Acta Crystallogr. D Biol. Crystallogr., 66, 486, 10.1107/S0907444910007493 · DOI · Paper page
  13. Fung, 2019, Human Coronavirus: Host-Pathogen Interaction, Annu. Rev. Microbiol., 73, 529, 10.1146/annurev-micro-020518-115759 · DOI · Paper page
  14. Goddard, 2007, Visualizing density maps with UCSF Chimera, J. Struct. Biol., 157, 281, 10.1016/j.jsb.2006.06.010 · DOI · Paper page
  15. Gristick, 2016, Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site, Nat. Struct. Mol. Biol., 23, 906, 10.1038/nsmb.3291 · DOI · Paper page
  16. Haagmans, 2014, Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation, Lancet Infect. Dis., 14, 140, 10.1016/S1473-3099(13)70690-X · DOI · Paper page
  17. Hoffmann, 2020, SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052 · DOI · Paper page
  18. Huang, 2021, Breadth and function of antibody response to acute SARS-CoV-2 infection in humans, PLoS Pathog., 17, e1009352, 10.1371/journal.ppat.1009352 · DOI · Paper page
  19. Huo, 2020, Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike, Cell Host Microbe, 28, 445, 10.1016/j.chom.2020.06.010 · DOI · Paper page
  20. Kabsch, 2010, XDS, Acta Crystallogr. D Biol. Crystallogr., 66, 125, 10.1107/S0907444909047337 · DOI · Paper page
  21. Kane, 2016, Identification of Interferon-Stimulated Genes with Antiretroviral Activity, Cell Host Microbe, 20, 392, 10.1016/j.chom.2016.08.005 · DOI · Paper page
  22. Klein, 2010, Few and far between: how HIV may be evading antibody avidity, PLoS Pathog., 6, e1000908, 10.1371/journal.ppat.1000908 · DOI · Paper page
  23. Kreer, 2020, Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients, Cell, 182, 843, 10.1016/j.cell.2020.06.044 · DOI · Paper page
  24. Krissinel, 2007, Inference of macromolecular assemblies from crystalline state, J. Mol. Biol., 372, 774, 10.1016/j.jmb.2007.05.022 · DOI · Paper page
  25. Landau, 2005, ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures, Nucleic Acids Res., 33, W299, 10.1093/nar/gki370 · DOI · Paper page
  26. Lefranc, 2009, IMGT, the international ImMunoGeneTics information system, Nucleic Acids Res., 37, D1006, 10.1093/nar/gkn838 · DOI · Paper page
  27. Lefranc, 2015, IMGT®, the international ImMunoGeneTics information system® 25 years on, Nucleic Acids Res., 43, D413, 10.1093/nar/gku1056 · DOI · Paper page
  28. Li, 2003, Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus, Nature, 426, 450, 10.1038/nature02145 · DOI · Paper page
  29. Li, 2005, Bats are natural reservoirs of SARS-like coronaviruses, Science, 310, 676, 10.1126/science.1118391 · DOI · Paper page
  30. Li, 2019, The human coronavirus HCoV-229E S-protein structure and receptor binding, eLife, 8, e51230, 10.7554/eLife.51230 · DOI · Paper page
  31. Liu, 2020, Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity, Immunity, 53, 1272, 10.1016/j.immuni.2020.10.023 · DOI · Paper page
  32. Liu, 2021, A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection, Cell Host Microbe, 29, 806, 10.1016/j.chom.2021.04.005 · DOI · Paper page
  33. Mastronarde, 2005, Automated electron microscope tomography using robust prediction of specimen movements, J. Struct. Biol., 152, 36, 10.1016/j.jsb.2005.07.007 · DOI · Paper page
  34. McCoy, 2007, Phaser crystallographic software, J. Appl. Cryst., 40, 658, 10.1107/S0021889807021206 · DOI · Paper page
  35. Pear, 1993, Production of high-titer helper-free retroviruses by transient transfection, Proc. Natl. Acad. Sci. USA, 90, 8392, 10.1073/pnas.90.18.8392 · DOI · Paper page
  36. Pettersen, 2004, UCSF Chimera—a visualization system for exploratory research and analysis, J. Comput. Chem., 25, 1605, 10.1002/jcc.20084 · DOI · Paper page
  37. Piccoli, 2020, Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology, Cell, 183, 1024, 10.1016/j.cell.2020.09.037 · DOI · Paper page
  38. Punjani, 2017, cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination, Nat. Methods, 14, 290, 10.1038/nmeth.4169 · DOI · Paper page
  39. Rappazzo, 2021, Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody, Science, 371, 823, 10.1126/science.abf4830 · DOI · Paper page
  40. Rogers, 2020, Rapid isolation of potent SARS-CoV-2 neutralizing antibodies and protection in a small animal model, bioRxiv
  41. Sauer, 2021, Structural basis for broad coronavirus neutralization, bioRxiv
  42. Schaefer, 2011, Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies, Proc. Natl. Acad. Sci. USA, 108, 11187, 10.1073/pnas.1019002108 · DOI · Paper page
  43. Scharf, 2015, Broadly Neutralizing Antibody 8ANC195 Recognizes Closed and Open States of HIV-1 Env, Cell, 162, 1379, 10.1016/j.cell.2015.08.035 · DOI · Paper page
  44. Scheid, 2011, Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding, Science, 333, 1633, 10.1126/science.1207227 · DOI · Paper page
  45. Scheid, 2021, B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV, Cell, 184, 3205, 10.1016/j.cell.2021.04.032 · DOI
  46. Schoofs, 2019, Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope, Immunity, 50, 1513, 10.1016/j.immuni.2019.04.014 · DOI · Paper page
  47. Shah, 2021, The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic, Front. Immunol., 12, 637651, 10.3389/fimmu.2021.637651 · DOI
  48. Sievers, 2011, Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega, Mol. Syst. Biol., 7, 539, 10.1038/msb.2011.75 · DOI · Paper page
  49. Song, 2005, Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human, Proc. Natl. Acad. Sci. USA, 102, 2430, 10.1073/pnas.0409608102 · DOI · Paper page
  50. Starr, 2021, Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape, bioRxiv
  51. Terwilliger, 2018, A fully automatic method yielding initial models from high-resolution cryo-electron microscopy maps, Nat. Methods, 15, 905, 10.1038/s41592-018-0173-1 · DOI · Paper page
  52. Tortorici, 2021, Broad sarbecovirus neutralization by a human monoclonal antibody, Nature, 597, 103, 10.1038/s41586-021-03817-4 · DOI · Paper page
  53. Wagh, 2016, Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection, PLoS Pathog., 12, e1005520, 10.1371/journal.ppat.1005520 · DOI · Paper page
  54. Walls, 2016, Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer, Nature, 531, 114, 10.1038/nature16988 · DOI · Paper page
  55. Wang, 2017, Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies, eLife, 6, e27389, 10.7554/eLife.27389 · DOI
  56. Wang, 2018, Serological Evidence of Bat SARS-Related Coronavirus Infection in Humans, China, Virol. Sin., 33, 104, 10.1007/s12250-018-0012-7 · DOI · Paper page
  57. Wang, 2021, A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies, Nat. Commun., 12, 1715, 10.1038/s41467-021-21968-w · DOI · Paper page
  58. Wec, 2020, Broad neutralization of SARS-related viruses by human monoclonal antibodies, Science, 369, 731, 10.1126/science.abc7424 · DOI · Paper page
  59. West, 2013, Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues, Proc. Natl. Acad. Sci. USA, 110, 10598, 10.1073/pnas.1309215110 · DOI
  60. West, 2021, SARS-CoV-2 lineage B.1.526 emerging in the New York region detected by software utility created to query the spike mutational landscape, bioRxiv
  61. Wrapp, 2020, Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science, 367, 1260, 10.1126/science.abb2507 · DOI · Paper page
  62. Yan, 2020, Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2, Science, 367, 1444, 10.1126/science.abb2762 · DOI · Paper page
  63. Yuan, 2017, Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains, Nat. Commun., 8, 15092, 10.1038/ncomms15092 · DOI · Paper page
  64. Yuan, 2020, A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV, Science, 368, 630, 10.1126/science.abb7269 · DOI · Paper page
  65. Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7 · DOI · Paper page
  66. Zhou, 2021, Identification of novel bat coronaviruses sheds light on the evolutionary origins of SARS-CoV-2 and related viruses, bioRxiv
  67. Zivanov, 2018, New tools for automated high-resolution cryo-EM structure determination in RELION-3, eLife, 7, e42166, 10.7554/eLife.42166 · DOI · Paper page
  68. Zost, 2020, Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein, Nat. Med., 26, 1422, 10.1038/s41591-020-0998-x · DOI · Paper page

Cited by

See all 116

Metadata

Authors
Jette, C. A., Cohen, A. A., Gnanapragasam, P. N. P., Muecksch, F., Lee, Y. E., Huey-Tubman, K. E., Schmidt, F., Hatziioannou, T., Bieniasz, P. D., Nussenzweig, M. C., West, A. P., Keeffe, J. R., Bjorkman, P. J., & Barnes, C. O.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2021-09
Volume
36
Issue
13
Pages
109760
ISSN
2211-1247 (ISSN-L)
OpenAlex
W3198731203
Cited by
116
References
38
FWCI
6.74
Type
journal article
Language
en
Update notices
erratum (2021-12-21)
Open access
gold
Licence
Funders
  • Rockefeller University
  • California Institute of Technology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies. https://app.cochat.ai/papers/10.1016/j.celrep.2021.109760
The paper
Jette, C. A., Cohen, A. A., Gnanapragasam, P. N. P., Muecksch, F., Lee, Y. E., Huey-Tubman, K. E., Schmidt, F., Hatziioannou, T., Bieniasz, P. D., Nussenzweig, M. C., West, A. P., Keeffe, J. R., Bjorkman, P. J., & Barnes, C. O. (2021). Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies. Cell Reports. https://doi.org/10.1016/j.celrep.2021.109760

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.